Don't hold your breath with MMJ publicity, although I'm led to believe HL Pharma is doing an outstanding job within pharmaceutical circles. Marketing regulations (ODC) will prohibit MMJ putting the capsules 'out there' to the broader market, so will have to rely on pharmacists, clinicians and educators to promote etc.
Satipharm have a CBD/THC blended capsule in development and will be ready for distribution next year if my mental filing cabinet serves me correctly.
In regards to the trials, PLT101 (epilepsy) hasn't fully recruited, and PTL201 (MS) hasn't started recruiting, therefore trial results won't be revealed until at least 2018 (later in the year for MS).
Hope that helps.
MMJ Price at posting:
46.5¢ Sentiment: Buy Disclosure: Held
